SCHEMBL11465708

SCHEMBL11465708

CN(C)C1CCCC1N(C(=O)C1CCC(Cl)C(Cl)C1)c1ccccc1

nearest known ligand 0.40

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
▸ CHRM2 P08172 2/20 0.40
▸ CHRM3 P20309 2/20 0.40
▸ MEN1 O00255 2/20 0.39
▸ KMT2A Q03164 2/20 0.39
▸ SMN1; SMN2 Q16637 2/20 0.39
▸ ALDH1A1 P00352 2/20 0.39
▸ KDM4E B2RXH2 1/20 0.39
▸ NPC1 O15118 1/20 0.39
▸ MITF O75030 1/20 0.39
▸ RAB9A P51151 1/20 0.39
▸ PAX8 Q06710 1/20 0.39
▸ FASN P49327 4/20 0.38
▸ LMNA P02545 1/20 0.38
▸ TSHR P16473 1/20 0.38
▸ HTT P42858 1/20 0.37
▸ PKM P14618 2/20 0.36
▸ TRPM8 Q7Z2W7 1/20 0.34
▸ OPRM1 P35372 1/20 0.34
▸ SIGMAR1 Q99720 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11341151 0.96 MEN1 (0.40) CHRM2CHRM3MEN1KMT2ASMN1; SMN2
SCHEMBL11341256 0.90 MEN1 (0.43) CHRM2CHRM3MEN1KMT2ASMN1; SMN2
SCHEMBL11510578 0.85 CHRM2 (0.38) CHRM2CHRM3MEN1KMT2ASMN1; SMN2
SCHEMBL11446586 0.82 ALDH1A1 (0.40) CHRM2CHRM3MEN1KMT2ASMN1; SMN2
SCHEMBL11455130 0.81 MEN1 (0.39) CHRM2CHRM3MEN1KMT2ASMN1; SMN2
SCHEMBL11447045 0.80 CHRM2 (0.40) CHRM2CHRM3MEN1KMT2ASMN1; SMN2
SCHEMBL11332174 0.79 ALDH1A1 (0.42) CHRM2CHRM3MEN1KMT2ASMN1; SMN2
SCHEMBL11330704 0.79 ALDH1A1 (0.39) CHRM2CHRM3MEN1KMT2ASMN1; SMN2
SCHEMBL11331824 0.78 PKM (0.39) CHRM2CHRM3MEN1KMT2ASMN1; SMN2
SCHEMBL11330925 0.78 KMT2A (0.39) CHRM2CHRM3MEN1KMT2ASMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-4156015-A N-(2-Aminocyclopentyl)acylanilides and treating depression THE UPJOHN COMPANY (US) 1979-05-22 — — US claimed
US-4204003-A N-(2-Aminocyclopentyl)-N-alkanoylanilides as CNS anti-depressants THE UPJOHN COMPANY (US) 1980-05-20 — — US disclosed
US-4159340-A N-(2-Aminocyclopentyl)-N-acylanilides as CNS anti-depressants THE UPJOHN COMPANY (US) 1979-06-26 — — US disclosed
US-4157398-A N-(2-Aminocyclopentyl)acylanilides and treating depression THE UPJOHN COMPANY (US) 1979-06-05 — — US disclosed
US-4156733-A ANTIDEPRESSANTS THE UPJOHN COMPANY (US) 1979-05-29 — — US disclosed
US-4156015-A N-(2-Aminocyclopentyl)acylanilides and treating depression THE UPJOHN COMPANY (US) 1979-05-22 — — US disclosed
US-4148913-A ANTIDEPRESSANTS THE UPJOHN COMPANY (US) 1979-04-10 — — US disclosed
Send feedback